Recombinant Human REV3L Protein，GST

REV3L, the catalytic subunit of the DNA polymerase zeta complex, plays a crucial role in DNA repair and translesion synthesis, allowing cells to bypass DNA lesions that could otherwise lead to replication forks stalling or cell death. Its involvement in various cellular processes makes it a significant focus in cancer research, as the dysregulation of REV3L has been linked to tumorigenesis and cancer progression. Investigations into REV3L’s function and regulation have unveiled its potential contributions to genomic instability, a hallmark of cancer, as well as its interactions with other proteins involved in the DNA damage response. Researchers are particularly interested in understanding how alterations in REV3L expression or activity can influence chemotherapy resistance, as well as its role in maintaining cellular homeostasis under stress conditions. This burgeoning field of study holds promise for developing novel therapeutic strategies that could enhance the efficacy of existing cancer treatments or target REV3L directly to inhibit its function in tumors that depend on its aberrant activity for survival. As such, REV3L represents a compelling target for future research aimed at elucidating its mechanisms and potential as a biomarker or therapeutic target in oncological contexts. The pursuit of a more comprehensive understanding of REV3L's biology may ultimately contribute to the ongoing challenge of overcoming cancer resistance and improving patient outcomes in clinical settings.